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A recombinant glycosylated avidin (recGAvi) with an acidic isoelectric point was expressed and secreted by the methylotrophic
yeast Pichia pastoris. The coding sequence for recGAvi was de novo synthesized based on the codon usage of P. pastoris. RecGAvi is
secreted at approximately 330mg/L of culture supernatant. RecGAvi monomer displays a molecular weight of 16.5 kDa, as assessed
by ESI mass spectrometry. N-terminal amino acid sequencing indicates the presence of three additional amino acids (E-A-E), which
contribute to further lowering the isoelectric point to 5.4. The data presented here demonstrate that the P. pastoris system is suitable
for the production of recGAvi and that the recombinant avidin displays biotin-binding properties similar to those of the hen-egg
white protein.
Keywords: Biotin–avidin technology; Low isoelectric point avidin; Pichia pastoris; High-cell-density fermentation; High-level expressionAvidin, a glycoprotein found in avian, reptilian, and
amphibian egg white, was ﬁrst noticed for its antinu-
tritive eﬀects [1,2]. The active form of hen-avidin is a
homotetramer composed of four singly glycosylated
subunits. Each monomer can bind a (+)-biotin molecule
with an extraordinary aﬃnity (Ka ¼ 1014 M1) [2]. (+)-
Biotin, which is commonly known as Vitamin H, is an
essential nutrient for most organisms. Since the growth
of various micro-organisms is inhibited by avidin, it is
believed that the proteins primary function is as a host
defense factor [3]. Recent studies demonstrate that avi-
din and some avidin-related genes are induced during
inﬂammation [4]. Moreover, the evidence that avidin
binds speciﬁcally heparin [5] and possibly its natural
counterparts, heparan sulfate proteoglycans that are
activated and secreted as part of normal defenses to
injury, stress or inﬂammation, reinforces the hypothesis* Corresponding authors. Fax: +21-32-718-22-01.
E-mail addresses: andrea.zocchi@unine.ch (A. Zocchi), thomas.
ward@unine.ch (T.R. Ward).that avidin plays a critical role in the innate immune
response.
The primary sequence of avidin (128 amino acids)
was determined in 1971 [6]. Kulomaa and co-workers
[7,8] documented the cDNA of the chicken oviduct av-
idin gene and isolated a genomic clone. The ﬁrst X-ray
structure of the biotin–avidin complex reported by Ba-
yer and co-workers [9], allowed to rationalize the
strength of the biotin–avidin interaction. The remark-
able stability of the biotin–avidin complex can be traced
back primarily to the following features:
(i) the depth of the biotin-binding pocket;
(ii) the H-bonding interactions between the polar ami-
no acid side chain residues (N12, S16, Y33, and
Y40) and the ureido ring;
(iii) the van-der-Waals contacts between the bicyclic
framework and aromatic amino acids of the protein
(W70, F72, F79, W97, and W110 from the adjacent
monomer) [9,10].
The primary source for the commercial production of
avidin is the extraction and puriﬁcation from chicken egg
white. More recently, biologically active recombinant
2isoforms have been produced in several expression sys-
tems, including Escherichia coli [11,12], Baculovirus-in-
fected cells [13] and maize [14].
The biotin–avidin technology has been utilized dur-
ing the last three decades for various biotechnological
applications, ranging from diagnostics to targeting
various materials both in vivo and in vitro [15]. How-
ever, the high-isoelectric point of avidin (pI¼ 10.5)
limits its ﬁeld of applications. The production of either
genetically [16,17] or chemically [18] modiﬁed avidin
allows one to overcome this problem. For example, the
existence of monomeric isoforms [19] makes avidin an
ideal partner for the expression of fusion proteins.
A non-glycosylated acidic mutant is particularly useful
in aﬃnity-based drug targeting [17]. Moreover, avidin
clones with a neutral or slightly acidic isoelectric point
were reported to be expressed at higher levels in diﬀerent
expression systems [16,20].
Yeast oﬀers an attractive alternative to the previously
reported expression systems for avidin. Saccharomyces
cerevisiae has been used extensively as a host for the
expression of foreign genes. This expression system
combines the advantages of microbial organisms with
those of eukaryotic organisms, namely the formation of
disulﬁde bridges and the glycosylation. However, the
frequent low production yields and the diﬃculties in
secreting some proteins have led to the investigation of
substitutes, such as the expression system based on
Pichia pastoris [21].
We are interested in producing artiﬁcial metalloen-
zymes based on the biotin–avidin technology [22]. TheFig. 1. Sequence of the artiﬁcial avidin reading frame (recGAvi) and its transl
yeast a-factor. The beginning of each synthetic fragment used in the synt
(GCGGCCGC) sites are underlined. The position of the PCR primers is indic
codon 1 and downstream of the stop codon (TAA) have been introduced by th
the ineﬀective STE13 sites by asterisks. The asparagine of the N-glycosylatiopossibility, given by P. pastoris, to obtain active avidin
directly in the medium provides an attractive alternative
to other expression systems, thus allowing one to screen
directly the culture medium as well as to conveniently
perform directed-evolution experiments.
Here, we report on the use of the methylotrophic
yeast P. pastoris to produce and secrete in its medium an
easily puriﬁable, fully active recombinant avidin.Materials and methods
Synthesis of the gene
The amino acid sequence of an avidin with an iso-
electric point of 7.2, which contained the K3E, K9D,
R122A, and R124A mutations [16], was back-translated
selecting the preferred codons inP. pastoris [23,24] (http://
www.kazusa.or.jp/codon). A non-glycosylated variant of
this avidin was produced ﬁrst. In this case, the asparagine
of theN-glycosylation site at position 17 [17] was replaced
by an isoleucine (N17I mutation). The resulting coding
strand (387 bp) was subdivided into six fragments chosen
to minimize the formation of secondary structures
(Fig. 1). Five shorter oligomers, on the antisense strand,
were synthesized across couples of adjacent coding frag-
ments, complementary with at least 15 bases to their ends,
except for their 30-base, to avoid a priming action in the
following PCR. All coding fragments, except the ﬁrst,
were 50-phosphorylated. All fragments, oligomers, and
primers were purchased from Microsynth, Switzerland.ation. The sequences in italic are vector-derived and encode part of the
hesis is highlighted by a dark box. The XhoI (CTCGAG) and NotI
ated by a line above the DNA sequence. The sequences upstream of the
e primers. The eﬀective cleavage of KEX2 site is indicated by an arrow,
n site is highlighted in a black box.
3An equimolar solution of fragments and oligomers in
standard T4-DNA ligase buﬀer [25] without adenosine-
triphosphate (ATP) and dithiothreitol (DTT) was pre-
pared. The tube containing the solution was heated at
98 C for 10min, to denature secondary structures, and
gently cooled to room temperature (RT) to anneal
coding fragments with antisense oligomers. ATP, DTT,
and T4-DNA ligase were subsequently added to perform
a ligation [25]. The ligation reaction was carried out for
24 h at RT. A high-ﬁdelity PCR (Expand High Fidelity
PCR system; Roche, Rotkreuz, Switzerland), with
primers containing XhoI and NotI restriction sites (un-
derlined in Fig. 1), was performed to obtain enough
material for cloning and sequencing. The forward pri-
mer (upperlined in Fig. 1) also contained a sequence
encoding the KEX2 and STE13 proteolytic sites, placed
upstream of the mature avidin-coding sequence. The
glycosylation site was reintroduced (vide supra) by high-
ﬁdelity PCR (Expand High Fidelity PCR system), uti-
lizing a 90 base oligomer as the 50 primer. This primer
included the C-terminal part of the a-factor coding se-
quence and a part of the mature avidin (bases from )21
to +67, Fig. 1).
Construction of the expression vector and transformation
The DNA fragment encoding the recombinant avidin
was inserted in-frame between the XhoI site, located in
the sequence coding for the a-factor signal peptide, and
the NotI site of P. pastoris expression vector pPIC 9K
(Invitrogen, Basel, Switzerland). This cloning step re-
quired the use of a SacI site from the vector and a li-
gation of three DNA fragments in order to leave intact
the second XhoI site of the plasmid. All enzymes and
buﬀers were purchased from Promega-Catalys, Wallis-
ellen, Switzerland, and the reaction conditions were set
as advised by the manufacturer.
Electrocompetent cells of P. pastoris GS115 (his4)
were transformed by electroporation with the expression
plasmid pPIC 9K—recGAvi or pPIC 9K—recNGAvi
(recombinant non-glycosylated avidin¼ recNGAvi; re-
combinant glycosylated avidin¼ recGAvi), which had
been linearized with SalI [21]. Transformants were
screened for Hisþ Mutþ phenotype [26,27].
Screening transformants for high-level expression
The ﬁlter-based colony immunodetection method,
termed ‘‘yeastern blot’’ [28], was used as a preliminary
screen to semi-quantitatively detect the clones express-
ing the highest levels of recombinant avidin.
The selected best clones, after two pre-cultures in
YPD (yeast extract 10 g/L, tryptone 20 g/L, and glucose
20 g/L), were cultured in 125mL of buﬀered YPD (YPD,
6mL/L of 1M K2HPO4, 40mL/L of 1M KH2PO4)
medium supplemented with 20 lL of sterile antifoam(SIGMA, Buchs, Switzerland). The cultures were incu-
bated at 30 C under shaking at 200 rpm. When the
cultures reached an OD600¼30 (about 24 h), cells were
collected, washed twice with sterile distilled water, and
resuspended into 125mL of buﬀered YPMetOH (con-
taining 10mL/L methanol instead of glucose). The ex-
pression was carried out for 4–5 days. Methanol
(1.2mL) and antifoam were added every 12 h. The clone
producing the most avidin, as detected by SDS–PAGE
as well as biotin-4-ﬂuorescein titration of binding sites,
was utilized for the fermentation.
Laboratory-scale high-cell-density fermentation
The fermentation was carried out in a laboratory
reactor (Bioengineering, Wald, Switzerland) of 3.6 L
total volume. The dissolved oxygen in the culture me-
dium was kept at least at 20% of its saturation value by
adding air and pure oxygen to the inlet gas ﬂow. The
total inlet gas ﬂow was kept at 4L/min. The pH was
kept constant by addition of 28% NH4OH. The tem-
perature and the stirring rate were kept constant
throughout the fermentation (30 C and 1300 rpm, re-
spectively).
All liquid inlet ﬂows were quantiﬁed gravimetrically.
The feed pump rate was controlled by a proportional
integral derivative (PID) controller based on the deriv-
ative of the reservoir scale.
The inoculum was prepared through two pre-cul-
tures. Initially, a colony of the best clone was inoculated
into 20mL YPD and incubated at 30 C for 24 h at
300 rpm. Ten milliliters was then inoculated into 75mL
of fermentation basal salts medium [29], pH 5. Glycerol
was present at a concentration of 20 g/L. This second
pre-culture was also incubated for 24 h. Sixty milliliters
of the second pre-culture were utilized to inoculate the
fermentor containing 1L of fermentation basal salts
medium [29], 40 g/L, glycerol supplemented with
4.35mL/L PTM1 solution [29] and 0.5mL/L antifoam
SAG 471.
After inoculation, the process was run until the
glycerol was consumed (23 h) [29]. During this phase,
the pH was maintained at 5. In the following glycerol-
fed phase, a continuous feed of 21mg/h of 50% glycerol
(w/v), supplemented with 12mL/L PTM2 solution (same
formulation as the PTM1 solution, but with biotin
eplaced by 1 g/L thiamine HCl, 1 g/L pyridoxine HCl,
1 g/L alanine, 0.5 g/L riboﬂavin, and 0.2 g/L inositol),
was provided. This phase lasted 5 h. During the glycerol
fed-batch phase, the pH control was stopped, allowing
the metabolic activity to lower the pH of the culture to
3. At this point, the pH-control was reactivated and set
to 3 for the remainder of the fermentation. In the
methanol fed-batch phase (induction phase), the meth-
anol was also supplemented with 12mL/L of PTM2
solution. The initial feed rate was 3.5mg/h and was
4gradually increased to 28mg/h. The fermentation was
stopped after about 65 h of induction (100 h total
fermentation time). The biomass measurements were
performed on the dry cell weight.
Puriﬁcation of recombinant avidin
The extracellular medium was diaﬁltrated and con-
centrated to 50mL using a Vivaﬂow 200 system 30000
MCWO (Sartorius, Sissach, Switzerland). During dia-
ﬁltration, the medium was exchanged with a buﬀered
solution at pH 9.8 containing 0.05M NaHCO3 and
0.5M NaCl. The proteic solution was then centrifuged
(47,000g for 20min at 4 C) and the supernatant was
ﬁltered again through a 0.45 lm ﬁlter. The resulting
clear solution was applied on a 2-iminobiotin–agarose
column. The protein was eluted applying 100mM acetic
acid, pH 2.9, [30]. The puriﬁed protein was immediately
dialyzed against 10mM Tris/HCl, pH 9.5, followed by
two dialyses against distilled water. The protein solution
was frozen at )80 C, lyophilized, and stored at 4 C.
Analytical methods
SDS–PAGE [31] and Western blot analysis [32–34]
were carried out with Bio-Rad equipment (Bio-Rad,
Reinach, Switzerland). Rabbit polyclonal anti-avidin
antibodies and goat anti-rabbit IgG alkaline phospha-
tase-conjugated antibodies (both from SIGMA, Buchs,
Switzerland) were utilized as primary and secondary
antibodies, respectively. Non-denaturing SDS–PAGE
was carried out as explained in [18].
The molecular mass of the expressed construct was
determined by electrospray ionization mass spectrome-
try (ESI-MS) (VG platform mass spectrometer, Micro-
mass instruments, Manchester, UK).
The N-terminal amino acid sequence was carried out
using Eldman degradation in a pulsed-liquid-phase se-
quenator 477A from Applied Biosystems. The released
amino acids were analyzed on-line by reversed phase
high-pressure liquid chromatography (RP-HPLC).
The functionality of the recombinant avidin was
checked by quantifying the proteins binding capacity to
the biotin-4-ﬂuorescein (Molecular Probe-Juro, Luzern,
Switzerland) [35]. This protocol allows us to determine
the concentration of the proteins active sites.Results and discussion
Gene construction and plasmid modiﬁcation
A gene encoding a recombinant avidin was synthe-
sized by PCR using synthetic oligonucleotides. The re-
sulting 426 bp coding sequence, encoding the proteolytic
signals KEX2 and STE13 fused to the mature avidin,was obtained (Fig. 1). This fragment was cloned in-
frame with the pro-peptide of the S. cerevisiae mating
factor a, contained in the expression vector pPIC 9K.
The insertion of this DNA in pPIC 9K replaced the
original C-terminal proteolytic recognition sequence by
a shorter one.
Automated DNA sequencing conﬁrmed the presence
of a single open reading frame coding for a translation
product of 216 amino acids, consisting of the modiﬁed
a-factor yeast secretion signal and the mature avidin.
Any sequence cloned in-frame with the C-terminal
a-factor coding sequence, contained in pPIC 9K is
expressed with additional (from 3 to 9) amino acids at
the N-terminal (manufacturers reference book). These
amino acids derive from the proteolytic processing of
the a-factor fused with the recombinant protein. We
shortened the a-factor sequence in order to reduce the
number of additional amino acids. The removal of this
sequence eliminates both the KEX2 and the STE13
protease sites, which are required for the maturation of
the recombinant protein. We thus reintroduced both the
proteolytic sites KEX2 (K-R) and STE13 (E-A-E) up-
stream of the N-terminal region of mature recombinant
avidin.
Expression and detection of recombinant avidin
After obtaining the artiﬁcial avidin sequence, it was
introduced into two types of plasmids for extracellular
expression (pPIC 9K and pHIL S1) following the
strategy suggested by the manufacturer. The two re-
combinant plasmids were then electroporated into two
Pichia strains (GS115 and SMD1168). The expression
levels were estimated by ‘‘yeastern’’ and Western blots.
The expression vector pPIC 9K in combination with
Pichia strain GS115 (phenotype Mutþ) was selected for
further use, as it aﬀorded the highest yields.
The immunodetection on ﬁlters (‘‘yeastern blot’’) was
used to conﬁrm the presence of the expression cassette in
transformants displaying a Hisþ Mutþ phenotype. As
shown in Fig. 2, the colonies expressing the recombinant
avidin leave a dark spot on the nitrocellulose membrane.
The colonies which reveal as the darkest stains were
cultured in shaking ﬂasks. The culture of the re-
combinant cells in shaking ﬂasks was not only used
to further screen for high-level expression clones, but
also allowed a ﬁrst characterization of the recombinant
avidin.
The non-glycosylated avidin was produced ﬁrst.
However, the SDS–PAGE of aliquots of culture me-
dium did not show the presence of any predominant
protein, when stained with Coomassie brilliant blue. In
addition, Western blotting (Fig. 3) suggested the pres-
ence of a truncated recombinant avidin smaller than
14.5 kDa, the computed molecular weight of the non-
glycosylated amino acid sequence of a monomer. The
Fig. 3. Immunoblot analysis of the medium of a baﬄed Erlenmeyer
ﬂask cell-culture expressing the non-glycosylated recombinant avidin
(after 105 h induction); (1) culture supernatant (20lL); (2) wild-type
avidin (10 ng).
Fig. 2. Example of a ‘‘yeastern’’ colony blot screen. Darker spots in-
dicate colonies expressing higher levels of recombinant avidin. The
arrow indicates the stain of a colony of which was transformed with an
empty pPIC 9K (negative control).
Fig. 4. SDS–PAGE of the medium of a baﬄed ﬂask culture expressing
the glycosylated recombinant avidin. Commercially available avidin
was utilized as standard and 15lL of culture supernatant was loaded
at diﬀerent induction times. (1) Wild-type avidin (40 lg): the high-
molecular weight band corresponds to a dimeric form of avidin; (2)
molecular mass markers; (3) sample before induction; (4) 12 h induc-
tion; (5) 24 h induction; (6) 36 h induction; (7) 48 h induction; (8) 60 h
induction; (9) 72 h induction; (10) 84 h induction; (11) 96 h induction;
and (12) 105 h induction.
Fig. 5. Biotin-binding activity test for recombinant avidin in the me-
dium of shaking ﬂask cultures. Binding activity is detected by ﬂuo-
rescence quenching; the maximal quenching occurs at saturation of the
tetravalent acceptor [35]. (j) Titration of 100ll of culture supernatant
the cells of which were transformed with empty pPIC 9K. (d) Titration
of 100ll of culture medium of one of the best clones. Both cultures
were induced in 105 h. The arrow indicates the equivalence point
(0.225 nmol of biotin-4-ﬂuorescein, corresponding to 0.056nmol of
tetrameric avidin).
5large hydrophobic isoleucine at position 17, replacing
the highly hydrophilic glycosylated asparagine, may
cause misfolding and expose the N-terminal part of the
protein to proteolytic degradation.
Considering these observations, the glycosylation site
was reintroduced (Fig. 1). After production and
screening of P. pastoris clones expressing the glycosy-
lated avidin, the sample collected during induction in-
deed contained a protein with the expected size. Fig. 4
displays the SDS–PAGE analysis of the culture super-
natant of the best clone, after staining with Coomassie
brilliant blue. Immunoblot analysis revealed a singleavidin band corresponding to the band in the SDS–
PAGE.
The biotin-binding activity was conﬁrmed by titrating
the culture medium of Pichia cells bearing pPIC 9K—
recGAvi with biotin-4-ﬂuorescein. Fig. 5 shows the
titration of the culture supernatant of the best clone.
The equivalence point, observed at 0.225 nmols of bio-
tin-4-ﬂuorescein added to 100 lL of the culture medium,
corresponds to 0.56 lM avidin (37mg/L), assuming a
tetrameric form of the recombinant avidin, with four
active-binding sites.
6High-cell-density fermentation
To obtain a large amount of active protein, the most
productive clone of the shaking ﬂask cultures was se-
lected for a fed-batch high-cell-density fermentation.
In contrast to standard Pichia fermentations, we
supplemented the carbon source of both the glycerol
fed- and the methanol fed-batch phases with PTM2 salts
instead of PTM1 salts. The PTM2 salts did not contain
biotin because its presence would severely hinder the
subsequent aﬃnity puriﬁcation of avidin by blocking the
binding sites. During glycerol fed- and methanol fed-
batch phases, the pH of the culture was gradually re-
duced and maintained at pH 3. Such a low pH is known
to inhibit neutral proteases secreted by Pichia [36].
During the initial glycerol-batch phase, the biomass
increased exponentially to 21 g/L (Fig. 6), with a maxi-
mal speciﬁc growth rate (lmax) of 0.24 h
1. Under these
conditions, the initial glycerol content was depleted
within 23 h. In the following phases, the biomass
concentration increased linearly to attain 44.5 g/L at the
end of the glycerol fed-batch phase and 160 g/L at the
end of the fermentation (Fig. 6). After 65 h of induction
(100 h of total culture time), the fermentation was
terminated and the medium was harvested. Indeed, even
in the presence of small amounts of methanol and
adding pure oxygen, the pO2 remained under 20%,
suggesting that the culture was too dense for an eﬃcient
oxygen transfer.
The biotin-binding activity of the culture medium was
ﬁrst determined 12 h after induction (42 h of total cul-
ture time, 0.38 lMbinding sites equivalent to6mg/L of
tetrameric avidin). Fig. 6 suggests that the biotin-4-
ﬂuorescein-binding response increases linearly through-
out the induction phase to reach21 lM (corresponding
to 5.2 lM of tetrameric avidin or 340mg/L).Fig. 6. High-cell-density fermentation of a clone expressing glycosy-
lated recombinant avidin. (j) Dry-cell weight per liter of culture
broth. (d) Concentration of biotin-binding sites in the medium
(binding activity).Characterization of recombinant avidin
The secreted recombinant avidin was puriﬁed from
the high-density-cell culture by aﬃnity chromatography
on a Sepharose–iminobiotin column to yield 330mg/L
(5.1 lM) avidin, which appears as a white ﬂuﬀy
material.
The puriﬁed recombinant avidin (recGAvi) was
dissolved in water and back-titrated with biotin-4-ﬂuo-
rescein [37] to determine its speciﬁc activity: 13.5U/
mg. This speciﬁc activity is comparable to the activities
of most common commercial avidins (10–15U/mg).
The N-terminal amino acid sequence of the re-
combinant avidin was determined as E-A-E-A-R-E-C-S.
From this sequence, it appears that the ﬁrst three amino
acids (underlined), part of the proteolytic site STE13
(E-A-E-A), are retained. Several cases of retention of
this sequence have been reported [38–40]. This suggests
that either the protein fold imposed by the sequence is
not suitable to recognition and proteolytic cleavage by
STE13 or that the amount of the protein produced ex-
ceeds the catalytic capacity of STE13 protease, pre-
venting the eﬀective cleavage of the fusion protein
formed by the a-factor signal and the recombinant avi-
din [38–40]. Considering this N-terminal modiﬁcation in
combination with the primary sequence containing the
K3E, K9D, R122A, and R124A mutations [16], the
isoelectric point of the recombinant avidin is estimated
at pI¼ 5.4 [41].
A ‘‘non-denaturing’’ SDS–PAGE [18] was performed
on puriﬁed recombinant avidin, redissolved in water, toFig. 7. Non-denaturing SDS–PAGE of puriﬁed recombinant avidin.
Under these conditions the protein (lane 1) migrates in the tetrameric
form.
Fig. 8. Positive ESI-MS of recGAvi (calculated mass of the main peak: 16350.3Da) dissolved in water/acetonitrile (1:1 v/v) containing 0.5% formic
acid.
7assess its quaternary state. The results unambiguously
show that the recombinant protein is tetrameric and
migrates as such (Fig. 7). Moreover, the fact that the
protein is able to enter the separating gel conﬁrms that
the pI of the recGAvi is signiﬁcantly lower than the pI
(10.5) of wild-type hen-egg white avidin [17,18].
ESI-MS of the puriﬁed recombinant avidin displayed
a main molecular peak centered at 16350.3Da, accom-
panied by periodic minor peaks (Fig. 8). The most in-
tense peak is attributed to monomeric avidin with a
single N-glycan (Man9-GlcNAc2, Man¼mannose,
GlcNAc¼N-acetyl-glucosamine) typical of P. pastoris
[42]. The minor peaks of higher molecular weight are
attributed to monoglycosylated monomeric avidin con-
taining additional mannose (Man9þn-GlcNAc2,
n ¼ 1–5).Conclusion
In this study, we have demonstrated that a glycosy-
lated recombinant avidin (recGAvi) can be produced at
330mg/L in the culture medium of the methylotrophic
yeast P. pastoris. This protocol allows a straightforward
puriﬁcation of the recombinant protein. Despite a low-
ered pI¼ 5.4, caused by K3E, K9D, R122A, and R124A
mutations and the additional N-terminal amino acids
(E-A-E) as well as a glycosylation pattern diﬀering from
the one of hen egg-white avidin, the recGAvi produced
in P. pastoris displays a speciﬁc activity very similar to
that of the commercial avidin.Acknowledgments
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